Pulse Biosciences, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $101.6M | $68.3M | $80.7M | $95.2M | $106.3M | $119.3M | $118.0M | $79.0M |
| Accounts Receivable | $122.0K | $157.0K | $274.0K | $15.0K | — | — | $0 | — |
| Inventory | $236.0K | $206.0K | $136.0K | $57.0K | $51.0K | $30.0K | $0 | — |
| Total Current Assets | $105.7M | $71.1M | $83.4M | $97.2M | $108.2M | $120.9M | $119.4M | $80.4M |
| Property, Plant & Equipment | $1.1M | $1.0M | $1.1M | $1.1M | $1.1M | $1.1M | $1.2M | $1.2M |
| Goodwill | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M |
| Intangible Assets (Excl. Goodwill) | $222.0K | $408.0K | $575.0K | $741.0K | $907.0K | $1.1M | $1.2M | $1.4M |
| Total Assets | $115.6M | $81.6M | $94.5M | $108.8M | $120.3M | $133.4M | $132.5M | $93.0M |
| Liabilities | ||||||||
| Accounts Payable | $2.8M | $2.8M | $2.8M | $3.0M | $2.7M | $2.4M | $1.7M | $1.7M |
| Total Current Liabilities | $11.0M | $9.8M | $7.9M | $9.7M | $9.0M | $7.8M | $10.1M | $6.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $16.1M | $15.3M | $13.9M | $16.1M | $15.8M | $14.9M | $17.6M | $13.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-506.5M | $-481.9M | $-463.3M | $-445.8M | $-426.5M | $-407.3M | $-390.5M | $-371.1M |
| Total Stockholders' Equity | $99.5M | $66.3M | $80.7M | $92.7M | $104.5M | $118.5M | $114.9M | $79.1M |